Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis; influence of H. pylori eradication. 2000

A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
Department of Pathophysiology, Medical School, University of Athens, 'Laikon General Hospital', Athens, Greece. aarchim@cc.uoa.gr

There is evidence that Helicobacter pylori infection up-regulates the expression of HLA class II molecules by gastric epithelial cells (GEC). In this study we evaluated whether GEC are capable of expression of costimulatory molecules in H. pylori gastritis. The expression of FasL by GEC, before and after eradication of H. pylori, was also studied. Thirty patients (23 men) aged 27-81 years (53.67 +/- 13.99 years (mean +/- s.d.)) with dyspepsia were studied. Upper gastrointestinal endoscopy was performed and six biopsies were obtained (antrum, n = 3; corpus, n = 3) for Campylobacter-Like Organisms (CLO) test and histology; 23 (16 men) were H. pylori+ and seven (all men) were H. pylori- by both methods and served as controls. Helicobacter pylori eradication therapy was given to H. pylori+ patients and all patients were re-endoscoped after 116 +/- 9 days. Formalin-fixed paraffin-embedded tissue sections were stained by the ABC immunoalkaline phosphatase method. In H. pylori gastritis HLA-DR was expressed and correlated with disease activity (P < 0.01). No HLA-DR was observed in controls. In H. pylori-eradicated patients significant decrease of HLA-DR was found (antrum, P < 0. 001). ICAM-1 was expressed by GEC in 80% of H. pylori+ patients; ICAM-1 expression did not correlate with gastritis parameters and decreased significantly after eradication (antrum, P < 0.01). B7-1 and B7-2 were expressed on H. pylori+ samples and their expression decreased after eradication, albeit not significantly. Weak epithelial expression of both B7 molecules was observed in all the controls. FasL was steadily expressed by GEC in both H. pylori+ and H. pylori- patients and remained almost unchanged after eradication. These findings suggest that GEC may acquire antigen-presenting cell properties in H. pylori infection through de novo expression of HLA-DR and costimulatory molecules. This seems to be attenuated after eradication and resolution of mucosal inflammation. The same cells exhibit the capacity to control the inflammatory process, probably by inducing apoptotic cell death to Fas-bearing infiltrating lymphocytes.

UI MeSH Term Description Entries
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
February 1991, Scandinavian journal of immunology,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
April 1994, Clinical and experimental immunology,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
April 1997, The Journal of clinical investigation,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
September 1992, Ophthalmology,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
November 1993, Gut,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
January 1998, Journal of cancer research and clinical oncology,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
May 1993, Cellular immunology,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
April 2000, Infection and immunity,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
July 1995, Clinical and experimental immunology,
A Archimandritis, and S Sougioultzis, and P G Foukas, and M Tzivras, and P Davaris, and H M Moutsopoulos
February 2006, Infection and immunity,
Copied contents to your clipboard!